Gene · 442909
Papers1,597
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,597
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Endometrial stromal cell miR-19b-3p release is reduced during decidualization implying a role in decidual-trophoblast cross-talk. | Front Endocrinol (Lausanne) | 2023 | 37008948 | PubTator, text mining | PubMed |
| Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature. | Front Mol Neurosci | 2023 | 37008787 | PubTator, text mining | PubMed |
| Analysis of the noncoding RNA regulatory networks of H37Rv- and H37Rv△1759c-infected macrophages. | Front Microbiol | 2023 | 36992931 | PubTator, text mining | PubMed |
| First-Trimester Screening for HELLP Syndrome-Prediction Model Based on MicroRNA Biomarkers and Maternal Clinical Characteristics. | Int J Mol Sci | 2023 | 36982251 | PubTator, text mining | PubMed |
| Exosome-Based Liquid Biopsy Approaches in Bone and Soft Tissue Sarcomas: Review of the Literature, Prospectives, and Hopes for Clinical Application. | Int J Mol Sci | 2023 | 36982236 | PubTator, text mining | PubMed |
| Non-Coding RNAs Modulating Estrogen Signaling and Response to Endocrine Therapy in Breast Cancer. | Cancers (Basel) | 2023 | 36980520 | PubTator, text mining | PubMed |
| The Implications of Microglial Regulation in Neuroplasticity-Dependent Stroke Recovery. | Biomolecules | 2023 | 36979506 | PubTator, text mining | PubMed |
| Potential miRNA-gene interactions determining progression of various ATLL cancer subtypes after infection by HTLV-1 oncovirus. | BMC Med Genomics | 2023 | 36978083 | PubTator, text mining | PubMed |
| Recent Progress in the Identification of Early Transition Biomarkers from Relapsing-Remitting to Progressive Multiple Sclerosis. | Int J Mol Sci | 2023 | 36901807 | PubTator, text mining | PubMed |
| Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment. | J Exp Clin Cancer Res | 2023 | 36899389 | PubTator, text mining | PubMed |
| Regulatory mechanisms of microRNAs in endocrine disorders and their therapeutic potential. | Front Genet | 2023 | 36896239 | PubTator, text mining | PubMed |
| Prognostic values of long noncoding RNA in bone metastasis of prostate cancer: A systematic review and meta-analysis. | Front Oncol | 2023 | 36890836 | PubTator, text mining | PubMed |
| Emerging role of interaction between m6A and main ncRNAs in gastrointestinal (GI) cancers. | Front Immunol | 2023 | 36875073 | PubTator, text mining | PubMed |
| Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers. | Front Immunol | 2023 | 36875063 | PubTator, text mining | PubMed |
| Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study. | Signal Transduct Target Ther | 2023 | 36864020 | PubTator, text mining | PubMed |
| MicroRNA-143-3p ameliorates collagen-induced arthritis by polarizing naive CD4+ T cells into Treg cells. | J Clin Lab Anal | 2023 | 36861291 | PubTator, text mining | PubMed |
| Potential miRNA biomarkers and therapeutic targets for early atherosclerotic lesions. | Sci Rep | 2023 | 36859458 | PubTator, text mining | PubMed |
| miRNAs in Herpesvirus Infection: Powerful Regulators in Small Packages. | Viruses | 2023 | 36851643 | PubTator, text mining | PubMed |
| Modulation of AKT Pathway-Targeting miRNAs for Cancer Cell Treatment with Natural Products. | Int J Mol Sci | 2023 | 36835100 | PubTator, text mining | PubMed |
| microRNAs (miRNAs) in Glioblastoma Multiforme (GBM)-Recent Literature Review. | Int J Mol Sci | 2023 | 36834933 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/442909/papers?page=7